Decode Civils CAShorts
Sci-TechPrelimsGS3

Bundibugyo Ebola: TUMAINI vaccine trial starts in DR Congo; outbreak reaches Nigeria

By CAShorts DeskPublished Sources: WHO (Disease Outbreak News, statements, guidance); ClinicalTrials.gov; MoHFW; PIB; Nigeria Health Ministry; The Hindu (AFP, AP)

Bundibugyo Ebola: TUMAINI vaccine trial starts in DR Congo; outbreak reaches Nigeria
Illustration (AI-generated)

The TUMAINI trial of vaccines against Bundibugyo virus disease, a form of Ebola, began in Bunia in the Democratic Republic of the Congo on 23 October 2026, vaccinating contacts of cases in rings. No vaccine or treatment is approved for this virus. On 20 October Nigeria became the outbreak's fifth affected country, after the DRC, Uganda, France and Kenya.

Syllabus: Prelims · Current Affairs & IR; GS3 · Science & Technology; GS2 · Health, Education & Human Resources

Why this matters for UPSC

GS2 (health, international institutions) and GS3 (science and technology). Prelims can ask about Ebola species and their vaccines, ring vaccination, CEPI and the IHR (2005) alert tiers; Mains, about the World Health Organization's emergency powers.

Why it matters

For families in eastern Congo, a vaccine that works would shield the people most exposed: the relatives, carers and health workers around each patient. Until then, control rests on finding cases fast, isolating and treating them, tracing contacts and burying the dead safely, and cases are still rising. Cases carried by air to Kenya and Nigeria show how one traveller can start a new cluster far away. That risk led India, in June, to start asking international air passengers to declare their recent travel. A clear trial result could change how every future Bundibugyo outbreak is fought. The larger question is how the world can have vaccines ready for rarer viruses before an epidemic begins, not only test them in the middle of one.

Prelims pointers

  • Orthoebolavirus: Ebola, Sudan and Bundibugyo viruses cause large outbreaks; vaccines are licensed against Ebola virus disease alone, and none against Sudan or Bundibugyo virus disease.
  • Ebola virus disease treatment: WHO strongly recommends two monoclonal antibodies, mAb114 (ansuvimab) and REGN-EB3 (Inmazeb); Sudan and Bundibugyo virus diseases have no approved therapeutic.
  • Under the International Health Regulations (2005), WHO is the secretariat, unable to compel countries or impose lockdowns; temporary recommendations lapse after three months, so Emergency Committees meet at least quarterly.
  • Pandemic emergency tier: adopted by the 77th World Health Assembly on 1 June 2024; in force from 19 September 2025, except for States Parties that rejected it.
  • Earlier Ebola PHEICs: the West Africa outbreak (declared 8 August 2014) and the outbreak in the DRC (declared 17 July 2019).
  • CEPI was launched on 18 January 2017 at the World Economic Forum, Davos; its founders were the governments of India and Norway, the Gates Foundation, Wellcome and the Forum.
  • ChAdOx1 is a replication-deficient chimpanzee adenovirus vector; Covishield, made by Serum Institute of India, uses it to encode the SARS-CoV-2 spike glycoprotein.
  • Pteropodidae fruit bats are thought to host Orthoebolaviruses and are the natural host of Nipah virus, first identified in Malaysia in 1998, with outbreaks in India since 2001.

Practise a UPSC-style question

With reference to the International Health Regulations (2005), consider the following statements:

1. The WHO Director-General determines whether an event is a public health emergency of international concern, considering, among other things, an Emergency Committee's advice.

2. Temporary recommendations issued by WHO during such an emergency are legally binding on States Parties.

3. The amended Regulations provide for a "pandemic emergency", a level of global alert above a public health emergency of international concern.

Which of the statements given above is/are correct?

  1. (a) 1 and 2 only
  2. (b) 2 and 3 only
  3. (c) 1 and 3 only
  4. (d) 1, 2 and 3
Show the answer

Answer: (c) 1 and 3 only

Answer: (c) 1 and 3 only. The Director-General decides a PHEIC and can now issue a higher alert, but temporary recommendations are only advice.

Statement 1: correct. Under Article 12 of the IHR (2005), the Director-General determines a PHEIC, considering the Emergency Committee's advice among other factors.

Statement 2: incorrect. WHO says temporary recommendations are, by definition, not legally binding; they guide countries and lapse after three months.

Statement 3: correct. Amendments adopted by the World Health Assembly on 1 June 2024, in force from 19 September 2025, added the pandemic emergency as the highest alert.

Eliminate: Judge statement 2 first: temporary recommendations are not binding, so statement 2 is incorrect. Out: (a), (b), (d).

Trap: Wrong scope. The IHR themselves bind States Parties, so it is tempting to treat WHO's temporary recommendations as binding too, though they are advisory.

Remember: IHR bind countries; temporary recommendations do not. A pandemic emergency sits above a PHEIC.

More from the 25 October 2026 edition

All stories of 25 October 2026

More Sci-Tech current affairs